Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Science Signaling
|
September 30, 2025
Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer
Priya S Hibshman, Clint A Stalnecker, Jeffrey A Klomp, et al.
Cell Reports
|
December 1, 2021
CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment
Jennifer E Klomp, Ye S Lee, Craig M Goodwin, et al.
Cancer Discovery
|
October 26, 2019
Atypical KRAS<sup>G12R</sup> Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer
G Aaron Hobbs, Nicole M Baker, Anne M Miermont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2024
Human Pancreatic Cancer Single-Cell Atlas Reveals Association of CXCL10+ Fibroblasts and Basal Subtype Tumor Cells
Ian M Loveless, Samantha B Kemp, Kailee M Hartway, et al.
Nature Medicine
|
June 3, 2020
Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Kirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.
Nature Medicine
|
March 6, 2019
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Kirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.
Cell Reports
|
June 17, 2026
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition
Andrew M Waters, Tala O Khatib, Bjoern Papke, et al.
Cell Reports
|
June 30, 2021
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition
Andrew M Waters, Tala O Khatib, Bjoern Papke, et al.
Nature
|
April 8, 2024
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Matthew Holderfield, Bianca J Lee, Jingjing Jiang, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Science Signaling
|
September 30, 2025
Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer
Priya S Hibshman, Clint A Stalnecker, Jeffrey A Klomp, et al.
Cell Reports
|
December 1, 2021
CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment
Jennifer E Klomp, Ye S Lee, Craig M Goodwin, et al.
Cancer Discovery
|
October 26, 2019
Atypical KRAS<sup>G12R</sup> Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer
G Aaron Hobbs, Nicole M Baker, Anne M Miermont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2024
Human Pancreatic Cancer Single-Cell Atlas Reveals Association of CXCL10+ Fibroblasts and Basal Subtype Tumor Cells
Ian M Loveless, Samantha B Kemp, Kailee M Hartway, et al.
Nature Medicine
|
June 3, 2020
Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Kirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.
Nature Medicine
|
March 6, 2019
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Kirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.
Cell Reports
|
June 17, 2026
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition
Andrew M Waters, Tala O Khatib, Bjoern Papke, et al.
Cell Reports
|
June 30, 2021
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition
Andrew M Waters, Tala O Khatib, Bjoern Papke, et al.
Nature
|
April 8, 2024
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Matthew Holderfield, Bianca J Lee, Jingjing Jiang, et al.
Page
of 3